Limb-Girdle Muscular Dystrophy Type 2I
Symptoms, Doctors, Treatments, Advances & More

Limb-Girdle Muscular Dystrophy Type 2I Overview

Save information for later
Sign Up

Learn About Limb-Girdle Muscular Dystrophy Type 2I

What is the definition of Limb-Girdle Muscular Dystrophy Type 2I?
Limb-girdle muscular dystrophy type 2I (LGMD2I) is a form of limb-girdle muscular dystrophy, which refers to a group of conditions that cause weakness and wasting of the muscles in the arms and legs. The proximal muscles (those closest to the body such as the upper arms and thighs) are generally most affected by the condition. In LGMD2I, specifically, signs and symptoms often develop in late childhood (average age 11.5 years) and may include difficulty running and walking. The symptoms gradually worsen overtime and affected people generally rely on a wheelchair for mobility approximately 23-26 years after onset. LGMD2I is caused by changes in the FKRP gene and is inherited in an autosomal recessive manner.
What are the alternative names for Limb-Girdle Muscular Dystrophy Type 2I?
  • Limb-girdle muscular dystrophy type 2I
  • Autosomal recessive limb-girdle muscular dystrophy type 2I
  • FKRP-related limb-girdle muscular dystrophy R9
  • FKRP-related LGMD R9
  • LGMD due to FKRP deficiency
  • LGMD type 2I
  • LGMD2I
  • Limb-girdle muscular dystrophy due to FKRP deficiency
  • Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5
Who are the top Limb-Girdle Muscular Dystrophy Type 2I Local Doctors?
Elite in Limb-Girdle Muscular Dystrophy Type 2I
Dr. Jeffrey M. Statland
Neurology
Elite in Limb-Girdle Muscular Dystrophy Type 2I
Dr. Jeffrey M. Statland
Neurology

Clinical Research Center

4350 Shawnee Mission Parkway, 
Fairway, KS 
913-588-1227
Experience:
21+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jeffrey Statland is a Neurologist practicing medicine in Fairway, Kansas. He has been practicing medicine for over 21 years. Dr. Statland is rated as an Elite provider by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2I. He is also highly rated in 50 other conditions, according to our data. His clinical expertise encompasses Facioscapulohumeral Muscular Dystrophy (FSHD), Paramyotonia Congenita, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, and Gastrostomy. Dr. Statland is board certified in American Board Of Psychiatry And Neurology, Neurology - 2011. Dr. Statland is currently accepting new patients.

Elite in Limb-Girdle Muscular Dystrophy Type 2I
Dr. Katherine Mathews
Pediatrics
Elite in Limb-Girdle Muscular Dystrophy Type 2I
Dr. Katherine Mathews
Pediatrics

University Of Iowa Stead Family Children's Hospital

200 Hawkins Dr, 
Iowa City, IA 
319-356-1851
Languages Spoken:
English
See accepted insurances

Katherine Mathews is a Pediatrics provider practicing medicine in Iowa City, Iowa. Dr. Mathews is rated as an Elite provider by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2I. She is also highly rated in 49 other conditions, according to our data. Her clinical expertise encompasses Limb-Girdle Muscular Dystrophy Type 2I, Limb-Girdle Muscular Dystrophy, Dystrophinopathy, and Friedreich Ataxia.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Limb-Girdle Muscular Dystrophy Type 2I
John Vissing
Elite in Limb-Girdle Muscular Dystrophy Type 2I
John Vissing
Centre De Référence De Pathologie Neuromusculaire Paris Est, 
EE 

John Vissing practices practicing medicine in Estonia. Mr. Vissing is rated as an Elite expert by MediFind in the treatment of Limb-Girdle Muscular Dystrophy Type 2I. He is also highly rated in 50 other conditions, according to our data. His clinical expertise encompasses Limb-Girdle Muscular Dystrophy, Myasthenia Gravis, Limb-Girdle Muscular Dystrophy Type 2I, and Pompe Disease.

View All Doctors
What are the latest Limb-Girdle Muscular Dystrophy Type 2I Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center